Vi anbefaler at du alltid bruker siste versjon av nettleseren din.
Illustrasjon: MDMA

MDMA Research

Our MDMA research focuses on evaluating MDMA-assisted therapy for severe psychiatric disorders and contributing to the international evidence base for MDMA-assisted treatments.

Our MDMA Research

Status: Completed
Funding: Helse Sør-Øst Regional Health Authority (HSØ) PhD Fellowship (~NOK 4 million)

MAT-MDD was the world's first clinical trial investigating MDMA-assisted therapy for major depressive disorder. The proof-of-principle study demonstrated that MDMA-assisted therapy was feasible and associated with clinically meaningful improvements in patients with treatment-resistant depression, providing the first evidence supporting further investigation of MDMA-assisted therapy for major depressive disorder. The findings were published in The British Journal of Psychiatry and the Journal of Psychiatric Research.

Principal Investigator: Ole A. Andreassen
PhD Candidate: Tor-Morten Kvam
Main Supervisor: Ole A. Andreassen
Co-supervisor: Lynn Egeland Mørch-Johnsen

Status: Completed

MP18 was a European multicentre Phase II clinical trial investigating MDMA-assisted therapy for post-traumatic stress disorder (PTSD). Østfold Hospital participated as one of the international study sites, contributing to the growing evidence base supporting MDMA-assisted psychotherapy.

Status: Planned (December 2026)
Funding: Helse Sør-Øst Regional Health Authority (HSØ) PhD Fellowship (~NOK 4 million) and the Norrsken Foundation (SEK 5 million)

The Empathy Project is a randomized pilot study evaluating MDMA-assisted therapy in young adults (18–25 years) with chronic treatment-resistant depression (TRD). The study will enroll 16 participants, randomized in a 1:1 ratio (2 × 8 participants), to evaluate the feasibility of recruitment, randomization, participant retention, study procedures, and treatment delivery. The project combines a randomized pilot trial with a single-case experimental design (SCED), enabling detailed longitudinal assessment of individual treatment trajectories and potential mechanisms of change. Together, these data will inform the design and implementation of a future larger randomized clinical trial.

Project Leads: Tor-Morten Kvam, Mark Berthold-Losleben and Ole A. Andreassen
PhD Candidate: Hilde Paulsen
Main Supervisor: Tor-Morten Kvam
Co-supervisors: Mark Berthold-Losleben and Ole A. Andreassen

Sist oppdatert 14.09.2026